AJU IB Investment Co., Ltd. Long-Term Concentrated

Location: Seoul, Korea, Republic of

CIK: 0001710065 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: Apr 8, 2025

Total Value: $84.04M (100.0% shares, 0.0% debt)

Holdings (8)

ACLX ARCELLX INC 81.8%

Value $68.72M Shares 1,047,557 Est. Cost $16.72 Unrealized +305.2%

KYMR KYMERA THERAPEUTICS INC 14.9%

Value $12.51M Shares 457,059 Est. Cost $48.78 Unrealized -25.3%

SEER SEER INC 1.6%

Value $1.38M Shares 816,375 Est. Cost $63.62 Unrealized -96.6%

— RALLYBIO CORP 0.6%

Value $494K Shares 754,678 Est. Cost $9.54 Unrealized —

XLO XILIO THERAPEUTICS INC 0.6%

Value $484K Shares 667,742 Est. Cost $17.03 Unrealized -94.7%

CARM CARISMA THERAPEUTICS INC 0.3%

Value $223K Shares 718,332 Est. Cost $0.82 Unrealized -46.2%

— RAPT THERAPEUTICS INC 0.1%

Value $121K Shares 99,503 Est. Cost $19.75 Unrealized —

— SUTRO BIOPHARMA INC 0.1%

Value $114K Shares 175,000 Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,047,557	$68.72M	81.8%	$16.72	+305.2%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	457,059	$12.51M	14.9%	$48.78	-25.3%	COM	501575104
SEER	SEER INC	816,375	$1.38M	1.6%	$63.62	-96.6%	COM CL A	81578P106
—	RALLYBIO CORP	754,678	$494K	0.6%	$9.54	—	COM	75120L100
XLO	XILIO THERAPEUTICS INC	667,742	$484K	0.6%	$17.03	-94.7%	COM	98422T100
CARM	CARISMA THERAPEUTICS INC	718,332	$223K	0.3%	$0.82	-46.2%	COM	14216R101
—	RAPT THERAPEUTICS INC	99,503	$121K	0.1%	$19.75	—	COM	75382E109
—	SUTRO BIOPHARMA INC	175,000	$114K	0.1%	$21.71	—	COM	869367102